Added to YB: 2025-02-04
Pitch date: 2025-02-04
ICAD [bullish]
iCAD, Inc.
+14.84%
current return
Author Info
Northeastern University Student Value Fund is the premier investment fund at Northeastern University. Visit their website.
Company Info
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.
Market Cap
$47.6M
Pitch Price
$3.37
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.90
P/E
-8.21
EV/Sales
1.57
Sector
Health Care Technology
Category
growth
Long $ICAD: Superior product suite with visibility into a high margin, recurring revenue stream from a transition to a cloud model
ICAD: AI mammography co. divested therapy biz for cloud focus. Superior product vs. competitors (23% more efficient, 50% less reading time). 80%+ GM, transitioning to SaaS. 17% market share. Risks: TAM penetration, revenue hit during model shift. Potential acquisition target. FDA approval for new product in 2025 catalyst.
Read full article (4 min)